Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Hutchison China Ads (HCM)

Hutchison China Ads (HCM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,906,267
  • Shares Outstanding, K 133,315
  • Annual Sales, $ 214,110 K
  • Annual Income, $ -74,800 K
  • 60-Month Beta 0.70
  • Price/Sales 13.80
  • Price/Cash Flow N/A
  • Price/Book 7.15

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 1 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/19
See More
  • Average Estimate N/A
  • Number of Estimates 0
  • High Estimate N/A
  • Low Estimate N/A
  • Prior Year N/A
  • Growth Rate Est. (year over year) unch

Price Performance

See More
Period Period Low Period High Performance
1-Month
20.81 +4.76%
on 07/02/19
30.30 -28.05%
on 06/27/19
-4.75 (-17.89%)
since 06/17/19
3-Month
20.81 +4.76%
on 07/02/19
30.80 -29.22%
on 04/22/19
-8.71 (-28.55%)
since 04/17/19
52-Week
20.81 +4.76%
on 07/02/19
39.68 -45.06%
on 11/14/18
-10.03 (-31.51%)
since 07/17/18

Most Recent Stories

More News
Edison Issues ADR Outlook on Hutchison China MediTech (HCM)

LONDON, UK / ACCESSWIRE / July 5, 2019 / Hutchison China MediTech (HCM) has announced positive data that key late-stage asset surufatinib met the primary endpoint of PFS in non-pancreatic at the Phase...

HCM : 21.80 (-1.62%)
Chi-Med to Announce 2019 Half-Year Financial Results

Hutchison China MediTech Limited ("Chi-Med") (AIM/Nasdaq: HCM) will be announcing its interim results for the six months ended June 30, 2019 on Tuesday, July 30, 2019 at 7:00 am British Summer Time (BST)...

HCM : 21.80 (-1.62%)
Chi-Med Announces Pricing of Upsized U.S. Public Secondary Offering of American Depositary Shares

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, IN OR INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OF SUCH JURISDICTION

CKHUF : 9.8000 (+0.72%)
HCM : 21.80 (-1.62%)
Chi-Med Announces Secondary Offering of American Depositary Shares

Hutchison China MediTech Limited ("Chi-Med") (AIM/Nasdaq: HCM) announces that Hutchison Healthcare Holdings Limited ("HHHL"), the largest shareholder of Chi-Med and a subsidiary of CK Hutchison Holdings...

CKHUF : 9.8000 (+0.72%)
HCM : 21.80 (-1.62%)
Deutsche Bank's Depositary Receipts Virtual Investor Conference presentations now available for On-Demand Viewing

Deutsche Bank today announced that the presentations from the May 15th and 16th Depositary Receipts Virtual Investor Conference ("dbVIC") are now available for on-demand viewing. The event featured presentations...

HCM : 21.80 (-1.62%)
ONE : 8.12 (-0.98%)
LAIX : 10.05 (+0.50%)
DB : 7.87 (-0.13%)
International companies to host live webcasts at Deutsche Bank's Depositary Receipts Virtual Investor Conference on May 15th and 16th, 2019

Deutsche Bank today announced the lineup for its Depositary Receipts Virtual Investor Conference ("dbVIC") on May 15(th) and 16(th), featuring live webcast presentations from international companies with...

HCM : 21.80 (-1.62%)
ONE : 8.12 (-0.98%)
LAIX : 10.05 (+0.50%)
DB : 7.87 (-0.13%)
Chi-Med Initiates a Phase IIb/III Trial of Surufatinib in Patients with Unresectable or Metastatic Biliary Tract Cancer in China

Hutchison China MediTech Limited ("Chi-Med") (AIM/Nasdaq: HCM) has initiated a registration-enabling Phase IIb/III study comparing surufatinib (HMPL-012 or sulfatinib) with capecitabine in patients with...

HCM : 21.80 (-1.62%)
Chi-Med Highlights Oral Presentations on Savolitinib Lung Cancer Programs at AACR Annual Meeting

Hutchison China MediTech Limited ("Chi-Med") (AIM/Nasdaq: HCM) will share further data on the savolitinib development programs in lung cancer at the American Association of Cancer Research (AACR) Annual...

HCM : 21.80 (-1.62%)
Chi-Med Reports 2018 Full Year Results and Provides Updates on Key Clinical Programs

Hutchison China MediTech Limited ("Chi-Med") (AIM/Nasdaq: HCM) today announces its audited financial results for the year ended December 31, 2018 and provides updates on key clinical programs.

HCM : 21.80 (-1.62%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Sell with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators fully support a continuation of the trend.

The market is approaching oversold territory. Be watchful of a trend reversal.

See More Share

Trade HCM with:

Business Summary

Hutchison China MediTech Limited researches, develops, manufactures and sells pharmaceuticals and health-related consumer products. The Company offers drugs for oncology and autoimmune diseases treatment. Hutchison China MediTech Limited is based in Hong Kong.

See More

Key Turning Points

2nd Resistance Point 22.41
1st Resistance Point 22.11
Last Price 21.80
1st Support Level 21.59
2nd Support Level 21.37

See More

52-Week High 39.68
Fibonacci 61.8% 32.47
Fibonacci 50% 30.24
Fibonacci 38.2% 28.02
Last Price 21.80
52-Week Low 20.81

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar